Ethambutol disposition in humans: Challenges and limitations of whole-body physiologically-based pharmacokinetic modelling in early drug development-Reference-Cited by-同舟云学术

Ethambutol disposition in humans: Challenges and limitations of whole-body physiologically-based pharmacokinetic modelling in early drug development

Published:2020-07 Issue: Volume:150 Page:105359
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Carrara Letizia,Magni Paolo,Teutonico Donato,Pasotti Lorenzo,Della Pasqua Oscar^ORCID,Kloprogge Frank^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference49 articles.

1. Effects of AIDS and gender on steady-state plasma and intrapulmonary ethambutol concentrations;Conte;Antimicrob. Agents Chemother.,2001

2. Modeling and comparison of dissolution profiles;Costa;Eur. J. Pharm. Sci.,2001

3. The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells;Dartois;Nat. Rev. Microbiol.,2014

4. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs;De Buck;Drug Metab. Dispos.,2007

5. Proceedings of WHO workshop on quality, good manufacturing practice and bioequivalence with a focus on antituberculotics: comparative dissolution testing and application;Dekker,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bayesian PBPK modeling using R/Stan/Torsten and Julia/SciML/Turing.Jl;CPT: Pharmacometrics & Systems Pharmacology;2023-02-05

2. Prediction of lung exposure to anti-tubercular drugs using plasma pharmacokinetic data: Implications for dose selection;European Journal of Pharmaceutical Sciences;2022-06

3. Development of physiologically‐based pharmacokinetic models for standard of care and newer tuberculosis drugs;CPT: Pharmacometrics & Systems Pharmacology;2021-10-08